Globus Medical

GMED.US ยท Healthcare ยท Medical Devices ยท USD ยท Fundamentals
Asset-light

Physical assets are 26.2% of total assets, a light footprint. Capex is 0.59x depreciation while free cash flow yield is positive, which can mean an aging base that is still throwing off cash. ROIC is 10.2%, above an 8% cost-of-capital hurdle.

Fixed-asset turnover is 4.68x. Compare it with other names in the same basket.

Physical asset ratio
26.2%
Net PP&E plus inventory, divided by total assets. Above 50% is a heavy footprint.
Fixed asset turnover
4.68x
Revenue per dollar of the physical asset base.
Capex / D&A
0.59x
Above 1.0x means the physical base is being replaced or expanded.
Tangible book / share
$17.44
Assets minus goodwill, intangibles, and liabilities, per share.
Price / tangible book
4.52x
Price $78.87.
Fixed-charge coverage
โ€”
EBITDA minus capex, divided by interest plus short-term debt.
FCF yield
5.7%
Latest free cash flow divided by current market cap ($10.25B).
ROIC
10.2%
After-tax operating income over equity plus debt minus cash. Operating income / net PP&E is 0.76x.

Footprint and return

Turnover and reinvestment

Year Physical FAT Capex/D&A TBV/sh Coverage FCF ROIC EBIT/PP&E
2018 23.3% 4.15x 1.43x $9.62 8.93x $121.95M โ€” 0.99x
2019 26.0% 3.88x 1.34x $11.71 1.72x $101.23M 12.9% 0.85x
2020 26.6% 3.64x 1.01x $12.50 1.12x $135.14M 8.3% 0.51x
2021 23.4% 4.33x 0.81x $14.41 2.00x $219.38M 10.9% 0.78x
2022 26.1% 4.20x 1.08x $15.45 13.74x $104.42M 12.7% 0.94x
2023 29.4% 2.42x 0.54x $14.30 8.36x $165.23M 2.5% 0.21x
2024 24.2% 4.12x 0.45x $14.14 0.80x $405.21M 3.7% 0.27x
2025 26.2% 4.68x 0.59x $17.44 โ€” $588.77M 10.2% 0.76x
  • Receivables are larger than the physical asset base, so a finance or credit book may sit outside the physical ratio and inside the debt used for coverage.
  • Principal due is short-term debt, the amount reported as due within a year.
Latest year inputs (2025)
Net PP&E: $628.24M
Inventory: $759.28M
Total assets: $5.30B
Goodwill: $1.44B
Intangibles: $745.06M
Liabilities: $729.51M
Tangible book: $2.39B
Shares: 137,219,388
Revenue: $2.94B
Capex: $164.68M
D&A: $276.84M
EBITDA: $886.74M
Interest: โ€”
Short-term debt: $14.74M
Free cash flow: $588.77M
Operating income: $479.80M
Invested capital: $4.13B
Tax rate: 11.8%